StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The firm has a market cap of $833,000.00, a PE ratio of -0.01 and a beta of -0.90. Athersys has a 52-week low of $0.01 and a 52-week high of $1.99.
Athersys Company Profile
See Also
- Five stocks we like better than Athersys
- Investing in the High PE Growth Stocks
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- What is the S&P/TSX Index?
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
